Skip to main content
Contact Us
Subscribe
E-Edition
67°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
EDIT
BLUE
VRTX
From
MarketWatch
1 Promising Stock Down 66% That Could Skyrocket in 2024
December 05, 2023
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Tickers
ARKG
BEAM
CRBU
CRSP
Tags
HOOD
PRME
VRTX
From
Motley Fool
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
November 29, 2023
Tickers
BLUE
EDIT
GPCR
Tags
Stocks to Buy
NASDAQ:EDIT,NASDAQ:BLUE,NASDAQ:GPCR
EDIT
From
InvestorPlace
Hidden Gems for Hefty Returns: 3 Stocks Set to Double Your Wealth Next Year
November 22, 2023
Tickers
AMD
EDIT
MARA
Tags
Stocks to Buy
MARA
EDIT
From
InvestorPlace
The 3 Best Gene Editing Stocks on the Frontier of Medicine
November 20, 2023
Tickers
ARKG
BEAM
EDIT
Tags
BEAM
Market News
EDIT
From
InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
November 20, 2023
Tickers
AAPL
BLUE
CRSP
EDIT
Tags
Market News
BLUE
EDIT
From
Motley Fool
3 Long-Term Growth Stocks Analysts Are Bullish On
November 16, 2023
Tickers
CRSP
EDIT
NVDA
SQ
Tags
Market News
NASDAQ:NVDA,NYSE:SQ,NASDAQ:EDIT,NASDAQ:CRSP
CRSP
From
InvestorPlace
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
Tickers
CRSP
EDIT
NTLA
REGN
Tags
Market News
NTLA
VRTX
From
InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Tickers
AGL
ALLO
AMCX
ATGL
Tags
VSME
CYTO
KN
From
Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
Tickers
ALLO
AMCX
AXL
CAH
Tags
IT
FIVN
RGEN
From
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Tickers
ACRE
AMCX
ARQT
ASIX
Tags
Earnings Scheduled
PRVA
FWONK
From
Benzinga
A Preview Of Editas Medicine's Earnings
November 02, 2023
Tickers
EDIT
Tags
EDIT
BZI/EP
Market News
From
Benzinga
Sent Your Boss The Message Meant For Your Girlfriend On Instagram — Now You Can Save Your Bacon
November 01, 2023
Tickers
EDIT
META
TECH
X
Tags
Tech
twitter
News
From
Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
Tickers
AMGN
BLUE
CRSP
EDIT
Tags
AMGN
CRSP
VRTX
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Tickers
ABNB
ALKS
AMZN
ANL
Tags
PSA
ANL
PVH
From
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
Tickers
BEAM
CRSP
EDIT
GNOM
Tags
Market News
GNOM
NASDAQ:EDIT,NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:NTLA,NASDAQ:BEAM
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Tickers
ALB
ALPN
ARM
BIP
Tags
FRLN
Downgrades
Initiation
From
Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
Tickers
BEAM
EDIT
Tags
Recent Press Releases
Market News
BEAM
From
Motley Fool
Analyst Ratings for Editas Medicine
October 18, 2023
Tickers
EDIT
Tags
EDIT
BZI/AAR
Analyst Ratings
From
Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
October 17, 2023
Tickers
BLUE
CRSP
EDIT
Tags
Expert Ideas
Briefs
CRSP
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Tickers
ACA
ACAD
ACDC
ACLX
Tags
GFL
TWKS
CYBR
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
Tickers
AHG
AMAM
ARDX
EDIT
Tags
NOK
ERIC
TTOO
From
InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 17, 2023
Tickers
AMAM
EDIT
ERIC
NOK
Tags
big losers
SPWR
Benzinga
From
Benzinga
Is Editas Stock a Buy Now?
October 07, 2023
Tickers
EDIT
Tags
Market News
Recent Press Releases
EDIT
From
Motley Fool
Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things
October 05, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
October 02, 2023
Tickers
CRSP
EDIT
Tags
Market News
Recent Press Releases
CRSP
From
Motley Fool
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Tickers
ADD
APRN
ASTI
BCLI
Tags
BNOX
Small Cap
RVLP
From
Benzinga
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
September 29, 2023
Tickers
CRSP
EDIT
Tags
General
Small Cap
Price Target
From
Benzinga
Why Editas Medicine Stock Is Soaring Today
September 29, 2023
Tickers
CRSP
EDIT
SF
VRTX
Tags
VRTX
CRSP
Recent Press Releases
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.